Scrotal mass screening: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Scrotal mass}} {{CMG}}{{AE}}{{SR}} ==Overview== According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend rout...") |
(Mahshid) |
||
| Line 17: | Line 17: | ||
{{WS}} | {{WS}} | ||
{{WH}} | {{WH}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Urology]] | |||
Revision as of 16:35, 27 November 2017
|
Scrotal Mass Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Scrotal mass screening On the Web |
|
American Roentgen Ray Society Images of Scrotal mass screening |
|
Risk calculators and risk factors for Scrotal mass screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for testicular cancer.[1]
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for testicular cancer.[1]
References
- ↑ 1.0 1.1 Screening of testicular cancer. U.S. Preventive Service Task Force 2016. http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/testicular-cancer-screening?ds=1&s=testicular%20cancer